CURE vs BUFS
Comparison between DIREXION DAILY HEALTHCARE BULL 3X SHARES (CURE, ETF) and FT VEST LADDERED SMALL CAP MODERATE BUFFER ETF (BUFS, ETF).
CURE vs BUFS - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Net Assets
CURE
$169M
Winner
BUFS
$169M
Expense Ratio
CURE
N/A
BUFS
1.01%
Max Drawdown
CURE
69.19%
Winner
BUFS
15.03%
Sharpe Ratio
CURE
1.14
Winner
BUFS
1.45
5Y Beta
CURE
1.31
Winner
BUFS
0.56
P/E Ratio
CURE
29.71
BUFS
N/A
Forward P/E
CURE
19.68
BUFS
N/A
5Y Dividends CAGR
CURE
116.94%
BUFS
N/A
5Y EPS CAGR
CURE
11.88%
BUFS
N/A
Debt to Equity
CURE
53.43%
BUFS
N/A
P/S Ratio
CURE
1.60
BUFS
N/A
P/B Ratio
CURE
5.00
BUFS
N/A
CURE vs BUFS - Holdings Comparison
CURE and BUFS have 0 common holdings. Overlap is 0.00%
CURE's top 25 holdings weight is 99.12%. BUFS's top 25 holdings weight is 99.92%.
| Rank | CURE | BUFS |
|---|---|---|
| #1 | HEALTH CARE SELECT SECTOR INDEX SWAP (n/a) - 12.57% | FT VEST US SM CP MOD BUFFR ETF- MAY (SMAY) - 25.05% |
| #2 | DREYFUS GOVT CASH MAN INS (n/a) - 11.34% | FT VEST U.S. SMALL CAP MOD BUF ETF-FEB (SFEB) - 25.05% |
| #3 | ELI LILLY AND CO (LLY) - 11.24% | FT VEST U.S. SM CP MOD BUF ETF -NOV (SNOV) - 24.93% |
| #4 | GOLDMAN FINL SQ TRSRY INST 506 (n/a) - 9.14% | FT VEST U.S. SM CP MOD BUF ETF -AUG (SAUG) - 24.89% |
| #5 | GOLDMAN SACHS FIN GOV 465 INSTITUT (n/a) - 7.97% | N/A |
| #6 | JOHNSON & JOHNSON (JNJ) - 7.29% | N/A |
| #7 | ABBVIE INC (ABBV) - 5.29% | N/A |
| #8 | UNITEDHEALTH GROUP INC (UNH) - 4.62% | N/A |
| #9 | MERCK & CO INC (MRK) - 3.69% | N/A |
| #10 | CASH (n/a) - 2.76% | N/A |
| #11 | AMGEN INC (AMGN) - 2.33% | N/A |
| #12 | THERMO FISHER SCIENTIFIC INC (TMO) - 2.28% | N/A |
| #13 | ABBOTT LABORATORIES (ABT) - 1.92% | N/A |
| #14 | GILEAD SCIENCES INC (GILD) - 1.87% | N/A |
| #15 | INTUITIVE SURGICAL INC (ISRG) - 1.70% | N/A |
| #16 | PFIZER INC (PFE) - 1.62% | N/A |
| #17 | CVS HEALTH CORP (CVS) - 1.60% | N/A |
| #18 | VERTEX PHARMACEUTICALS INC (VRTX) - 1.51% | N/A |
| #19 | DANAHER CORP (DHR) - 1.46% | N/A |
| #20 | BRISTOL-MYERS SQUIBB CO (BMY) - 1.37% | N/A |
| #21 | STRYKER CORP (SYK) - 1.29% | N/A |
| #22 | MEDTRONIC PLC (MDT) - 1.21% | N/A |
| #23 | MCKESSON CORP (MCK) - 1.10% | N/A |
| #24 | ELEVANCE HEALTH INC (ELV) - 1.08% | N/A |
| #25 | THE CIGNA GROUP (CI) - 0.87% | N/A |
| Total Holdings | 65 | 4 |
CURE vs BUFS - Historical Returns
Returns include dividend reinvestment.
1M
Winner
CURE
+19.37%
BUFS
+0.57%
3M
Winner
CURE
+27.21%
BUFS
+4.36%
6M
CURE
-2.58%
Winner
BUFS
+6.90%
1Y
Winner
CURE
+60.77%
BUFS
+17.61%
5Y(CAGR)
CURE
+1.48%
BUFS
N/A
10Y(CAGR)
CURE
+13.11%
BUFS
N/A
Max(CAGR)
Winner
CURE
+23.97%
BUFS
+11.30%
CURE vs BUFS - Annual Returns (2011 - 2026)
Returns include dividend reinvestment.
| Year | CURE | BUFS |
|---|---|---|
| 2026 | +1.71% | +9.36% |
| 2025 | +22.87% | +7.03% |
| 2024 | -12.90% | +6.83% |
| 2023 | -8.46% | N/A |
| 2022 | -17.91% | N/A |
| 2021 | +90.55% | N/A |
| 2020 | +4.13% | N/A |
| 2019 | +62.36% | N/A |
| 2018 | -0.75% | N/A |
| 2017 | +62.77% | N/A |
| 2016 | -12.42% | N/A |
| 2015 | +6.24% | N/A |
| 2014 | +83.03% | N/A |
| 2013 | +153.15% | N/A |
| 2012 | +45.79% | N/A |
| 2011 | -9.68% | N/A |
CURE vs BUFS Drawdown Comparison
The maximum drawdown for CURE was -69.19%, occurring on Mar 23, 2020. Recovery took 242 trading sessions.
The maximum drawdown for BUFS was -15.03%, occurring on Apr 8, 2025. Recovery took 187 trading sessions.
The current CURE drawdown is -18.27%.
| Rank | CURE | BUFS |
|---|---|---|
| #1 | -69.19% Jan 22, 2020 - Jan 6, 2021 | -15.03% Dec 4, 2024 - Sep 5, 2025 |
| #2 | -52.25% Apr 8, 2022 - Aug 7, 2025 | -5.36% Jul 16, 2024 - Aug 26, 2024 |
| #3 | -48.54% Jul 20, 2015 - Jun 22, 2017 | -4.68% Oct 27, 2025 - Dec 10, 2025 |
| #4 | -44.44% Jul 1, 2011 - Mar 15, 2012 | -4.02% Feb 25, 2026 - Apr 9, 2026 |
| #5 | -42.27% Oct 1, 2018 - Nov 27, 2019 | -2.82% Aug 30, 2024 - Sep 19, 2024 |
| #6 | -36.35% Jan 26, 2018 - Sep 13, 2018 | -1.81% Oct 8, 2025 - Oct 14, 2025 |
| #7 | -29.28% Dec 30, 2021 - Apr 8, 2022 | -1.77% May 31, 2024 - Jul 11, 2024 |
| #8 | -22.89% Aug 17, 2021 - Dec 15, 2021 | -1.68% Nov 11, 2024 - Nov 22, 2024 |
| #9 | -22.59% Sep 24, 2014 - Oct 28, 2014 | -1.48% Oct 16, 2024 - Nov 6, 2024 |
| #10 | -19.78% Mar 4, 2014 - Jun 19, 2014 | -1.44% Jan 22, 2026 - Feb 9, 2026 |
| #11 | -19.31% Oct 17, 2012 - Jan 9, 2013 | -1.34% Dec 11, 2025 - Jan 6, 2026 |
| #12 | -19.31% Jan 20, 2021 - Apr 15, 2021 | -1.34% Sep 19, 2024 - Oct 14, 2024 |
| #13 | -17.38% Apr 2, 2012 - Jun 29, 2012 | -1.33% Jun 4, 2026 - Jun 12, 2026 |
| #14 | -15.49% May 28, 2013 - Jul 12, 2013 | -1.27% May 14, 2026 - May 21, 2026 |
| #15 | -14.96% Dec 8, 2014 - Jan 22, 2015 | -1.06% Sep 18, 2025 - Oct 2, 2025 |
Correlation
Correlation between CURE and BUFS is 0.03 which considered as a very weak or no correlation - the stocks move independently of each other.
0.03
-101
Select Stocks to Compare
Popular: CURE vs SPYBUFS vs SPY
More Comparisons
Compare with similar stocks